PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 8630574

  • 1. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate.
    Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, Swinkels LM, van Herwaarden CL.
    Am J Respir Crit Care Med; 1996 Mar; 153(3):924-30. PubMed ID: 8630574
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
    Pauwels RA, Yernault JC, Demedts MG, Geusens P.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A, Hall I, Spelman R.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [Abstract] [Full Text] [Related]

  • 4. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
    Malo JL, Cartier A, Ghezzo H, Mark S, Brown J, Laviolette M, Boulet LP.
    Eur Respir J; 1999 May; 13(5):993-8. PubMed ID: 10414395
    [Abstract] [Full Text] [Related]

  • 5. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
    Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL.
    Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
    [Abstract] [Full Text] [Related]

  • 6. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.
    Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A.
    Allergol Immunopathol (Madr); 2001 Jun; 29(1):22-7. PubMed ID: 11449531
    [Abstract] [Full Text] [Related]

  • 7. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.
    Lorentzen KA, Van Helmond JL, Bauer K, Langaker KE, Bonifazi F, Harris TA.
    Respir Med; 1996 Nov; 90(10):609-17. PubMed ID: 8959118
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
    Barnes NC, Hallett C, Harris TA.
    Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years.
    Egan JJ, Maden C, Kalra S, Adams JE, Eastell R, Woodcock AA.
    Eur Respir J; 1999 Jun; 13(6):1267-75. PubMed ID: 10445600
    [Abstract] [Full Text] [Related]

  • 10. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
    Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, van Herwaarden CL.
    Thorax; 1995 Oct; 50(10):1044-50. PubMed ID: 7491551
    [Abstract] [Full Text] [Related]

  • 11. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
    Ohbayashi H, Adachi M.
    Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
    [Abstract] [Full Text] [Related]

  • 12. Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma.
    Fitzgerald D, Van Asperen P, Mellis C, Honner M, Smith L, Ambler G.
    Thorax; 1998 Aug; 53(8):656-61. PubMed ID: 9828851
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
    Horiguchi T, Hayashi N, Ohira D, Torigoe H, Ito T, Hirose M, Sasaki Y, Shiga M, Miyazaki J, Kondo R, Tachikawa S.
    J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
    [Abstract] [Full Text] [Related]

  • 14. A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma.
    Leblanc P, Mink S, Keistinen T, Saarelainen PA, Ringdal N, Payne SL.
    Allergy; 1994 May; 49(5):380-5. PubMed ID: 8092438
    [Abstract] [Full Text] [Related]

  • 15. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
    Fabbri L, Burge PS, Croonenborgh L, Warlies F, Weeke B, Ciaccia A, Parker C.
    Thorax; 1993 Aug; 48(8):817-23. PubMed ID: 8211872
    [Abstract] [Full Text] [Related]

  • 16. Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma.
    Bootsma GP, Koenderman L, Dekhuijzen PN, Festen J, Lammers JW, van Herwaarden CL.
    Allergy; 1998 Jul; 53(7):653-61. PubMed ID: 9700034
    [Abstract] [Full Text] [Related]

  • 17. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.
    Boe J, Bakke P, Rødølen T, Skovlund E, Gulsvik A.
    Eur Respir J; 1994 Dec; 7(12):2179-84. PubMed ID: 7713201
    [Abstract] [Full Text] [Related]

  • 18. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
    Lawrence M, Wolfe J, Webb DR, Chervinsky P, Kellerman D, Schaumberg JP, Shah T.
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):744-51. PubMed ID: 9309988
    [Abstract] [Full Text] [Related]

  • 20. Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma.
    O'Connor BJ, Löfdahl CG, Balter M, Szczeklik A, Boulet LP, Cairns CB.
    Respir Med; 2007 Jun; 101(6):1088-96. PubMed ID: 17360171
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.